Literature DB >> 21455204

Parathyroid tumors and related disorders.

Ronald A DeLellis1.   

Abstract

Primary hyperparathyroidism (P-HPT) is a common endocrine disorder that occurs as a result of adenomas (80-85%), hyperplasias (10-15%) or carcinomas (<1%) of the parathyroid glands. Molecular genetic analyses of heritable P-HPT syndromes have provided considerable insight into the understanding of sporadic parathyroid tumors and hyperplasias. This review will focus on the criteria for classification of parathyroid proliferative disorders and will highlight our understanding of these lesions at the molecular level. Advances in radiological imaging techniques together with the rapid intraoperative parathyroid hormone assay will be reviewed with respect to current treatment approaches for P-HPT.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21455204     DOI: 10.1038/modpathol.2010.132

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  32 in total

1.  Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism.

Authors:  Andrew J Lowell; Norah M Bushman; Xing Wang; Yue Ma; Susan C Pitt; Rebecca S Sippel; David F Schneider; Reese W Randle
Journal:  J Surg Res       Date:  2017-07-12       Impact factor: 2.192

2.  Three-Dimensional Computed Tomography Reconstruction for Revision Parathyroidectomy.

Authors:  Navdeep R Sayal; Ryan J Brisson; Kenneth Richey; Christine Lepoudre
Journal:  Cureus       Date:  2017-09-26

3.  Polyclonal origin of parathyroid tumors is common and is associated with multiple gland disease in primary hyperparathyroidism.

Authors:  Yuhong Shi; Pedram Azimzadeh; Sarada Jamingal; Shannon Wentworth; Janice Ferlitch; James Koh; Nariman Balenga; John A Olson
Journal:  Surgery       Date:  2018-01       Impact factor: 3.982

Review 4.  Neuroendocrine Tumors of the Thyroid and Their Mimics.

Authors:  Virginia A Livolsi
Journal:  Endocr Pathol       Date:  2021-03-09       Impact factor: 3.943

5.  Role of Histological Criteria and Immunohistochemical Markers in Predicting Risk of Malignancy in Parathyroid Neoplasms.

Authors:  Niraj Kumari; Nandita Chaudhary; Roma Pradhan; Amit Agarwal; Narendra Krishnani
Journal:  Endocr Pathol       Date:  2016-06       Impact factor: 3.943

6.  Non-functioning parathyroid cystic tumour: malignant or not? Report of a case.

Authors:  G Cocorullo; G Scerrino; G Melfa; C Raspanti; G Rotolo; V Mannino; P Richiusa; D Cabibi; A G Giannone; C Porrello; G Gulotta
Journal:  G Chir       Date:  2017 Sep-Oct

Review 7.  A Herald of Plasma Cell Myeloma: A Report of Malignant Plasma Cells Identified in Parathyroid Adenoma and a Review of Non-parathyroid Malignancies in Parathyroid Glands.

Authors:  Vincent Cracolici; Raymon H Grogan; Madina Sukhanova; Jason X Cheng; Sandeep Gurbuxani; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2017-10-13

8.  Oxyphil Cell Parathyroid Adenomas Causing Primary Hyperparathyroidism: a Clinico-Pathological Correlation.

Authors:  Pamela Howson; Schelto Kruijff; Ahmad Aniss; Thomas Pennington; Anthony J Gill; Tristan Dodds; Leigh W Delbridge; Stan B Sidhu; Mark S Sywak
Journal:  Endocr Pathol       Date:  2015-09       Impact factor: 3.943

Review 9.  The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.

Authors:  Shilpa Thakur; Brianna Daley; Joanna Klubo-Gwiezdzinska
Journal:  J Mol Endocrinol       Date:  2019-08       Impact factor: 5.098

Review 10.  Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.